Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine

Acta Pharmacologica Sinica

Volumn 20, Issue 4, 1999, Pages 375-380

  Li, Jin ^a   Li, Xin ^a   Pei, Gang ^a,b   Qin, Bo Yi ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Agmatine; Brain; Dizocilpine; Drug tolerance; Idazoxan; Morphine; Naloxone; Nitric oxide; Nitric oxide synthase; Opioid related disorders

Indexed keywords

AGMATINE; CITRULLINE; CLONIDINE; DIZOCILPINE; IDAZOXAN; MORPHINE; N(G) NITROARGININE; NALOXONE; NITRIC OXIDE SYNTHASE;

ARTICLE; CEREBELLUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; FOREBRAIN; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS;

AGMATINE; ANIMALS; BRAIN; MALE; MICE; MORPHINE DEPENDENCE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032909626     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bhargava HN. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol Rev 1994; 46: 293-324.
2. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385-8.
3. Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein PL. NMDA receptor antagonists suppress behaviors but not norepinephrine turn over or locus coeruleus unit activity induced by opiate withdrawal. Eur J Pharmacol 1991; 197: 9-16.
4. Cappendijk SLT, de Vries R, Dzoljic MR. Inhibitory effect of nitric oxide (NO) synthase inhibitor on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett 1993; 162: 97-100.
5. Leza JC, Lizasoain I, Cuellar B, Moro MA, Lorenzo P. Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn-Schmiedebergs Arch Pharmacol 1996; 353: 349-51.
6. Kolesnikov Y, Jain S, Pasternak GW. Modulation of opioid analgesia by agmatine. Eur J Pharmacol 1996; 296: 17-22.
7. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996; 316: 247-9.
8. Fukuto JM, Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 1995; 35: 165-91.
9. Regunathan S, Feinstein DL, Raasch W, Reis DJ. Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport 1995; 6: 1897-900.
10. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.